
Hyperpigmentation Disorder Treatment Market Report 2026
Global Outlook – By Treatment Type (Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion), By Disease Indication (Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines), By End-Users (Hospitals, Esthetic Clinics And Dermatology Centers) - Market Size, Trends, And Global Forecast 2026-2035
Hyperpigmentation Disorder Treatment Market Overview
• Hyperpigmentation Disorder Treatment market size has reached to $6.12 billion in 2025 • Expected to grow to $9.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.9% • Growth Driver: Cosmetic Concerns Propel Surge In Hyperpigmentation Disorder Treatment Market • Market Trend: Innovative Applicator Designs Driving Growth In The Hyperpigmentation Disorders Treatment Market • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.What Is Covered Under Hyperpigmentation Disorder Treatment Market?
Hyperpigmentation disorder treatment refers to the various methods used to reduce the appearance of dark spots or patches on the skin that occur due to excess melanin production. Topical creams containing ingredients such as hydroquinone, vitamin C, and azelaic acid can be used to lighten the skin. The treatment types involved in the hyperpigmentation disorder treatment market include cosmeceuticals, laser therapy, chemical peels, microdermabrasion, phototherapy and other treatments. Cosmeceuticals are cosmetics with active ingredients that may be therapeutic for the skin. They are used to treat various diseases including melasma, post-inflammatory hyperpigmentation, solar lentigines and other indications by various end-users such as hospitals, esthetic clinics and dermatology centers and other end-users.
What Is The Hyperpigmentation Disorder Treatment Market Size and Share 2026?
The hyperpigmentation disorder treatment market size has grown strongly in recent years. It will grow from $6.12 billion in 2025 to $6.65 billion in 2026 at a compound annual growth rate (CAGR) of 8.5%. The growth in the historic period can be attributed to increasing prevalence of melasma and PIH, rising aesthetic awareness, growth of dermatology clinics, widespread use of topical depigmenting agents, increasing sun exposure.What Is The Hyperpigmentation Disorder Treatment Market Growth Forecast?
The hyperpigmentation disorder treatment market size is expected to see strong growth in the next few years. It will grow to $9.36 billion in 2030 at a compound annual growth rate (CAGR) of 8.9%. The growth in the forecast period can be attributed to growing demand for laser and energy-based devices, expansion of personalized skincare treatments, rising disposable income, increased adoption of combination therapies, growing influence of aesthetic medicine. Major trends in the forecast period include growing demand for non-invasive aesthetic treatments, rising preference for combination therapy approaches, increased use of preventive and maintenance skincare regimens, expansion of medical-grade cosmeceuticals, higher adoption of clinic-based advanced procedures.Global Hyperpigmentation Disorder Treatment Market Segmentation
1) By Treatment Type: Cosmeceuticals, Laser Therapy, Chemical Peels, Microdermabrasion 2) By Disease Indication: Melasma, Post-Inflammatory Hyperpigmentation, Solar Lentigines 3) By End-Users: Hospitals, Esthetic Clinics And Dermatology Centers Subsegments: 1) By Cosmeceuticals: Topical Creams and Gels, Serums and Lotions 2) By Laser Therapy: Fractional Laser Resurfacing, Intense Pulsed Light (IPL) Therapy 3) By Chemical Peels: Superficial Peels, Medium Depth Peels 4) By Microdermabrasion: Crystal Microdermabrasion, Diamond MicrodermabrasionWhat Is The Driver Of The Hyperpigmentation Disorder Treatment Market?
The rising cosmetic concerns are expected to propel the growth of the hyperpigmentation disorder treatment market going forward. Cosmetic concerns refer to worries or considerations related to the appearance, beauty, or aesthetics of one's physical features. Rising cosmetic concerns help to seek and engage in hyperpigmentation disorder treatments, driving innovation in the cosmetic and dermatological industries and improving the overall patient experience. For instance, in March 2025, according to the Yellow Bus ABA, a US-based therapy group, in 2023, the global plastic surgery sector saw notable activity, with around 34.9 million aesthetic procedures performed worldwide, marking a 3.4% rise compared to 2022. Therefore, rising cosmetic concerns are driving the growth of the hyperpigmentation disorder treatment industry.Key Players In The Global Hyperpigmentation Disorder Treatment Market
Major companies operating in the hyperpigmentation disorder treatment market are Vivier Pharma, Obagi Cosmeceuticals LLC, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, La Roche-Posay, L'Oréal S.A., Pierre Fabre Laboratories, Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estée Lauder Companies Inc.Global Hyperpigmentation Disorder Treatment Market Trends and Insights
Major companies operating in the hyperpigmentation disorders treatment market are focused on developing glycolic acid solutions to strengthen their position and gain a competitive advantage. Glycolic acid solutions refer to skincare formulations containing glycolic acid, an alpha hydroxy acid (AHA) known for its exfoliating properties, which help improve skin texture, brightness, and overall appearance by promoting cell turnover. For instance, in February 2024, L'Oréal SA, a France-based personal care corporation, launched the Glycolic Bright Dark Circle Eye Serum, targeting dark circles and dullness around the eyes. This innovative serum features glycolic acid for its exfoliating properties, promoting brighter skin and improved texture. The formula also likely includes hydrating ingredients to nourish the delicate eye area.What Are Latest Mergers And Acquisitions In The Hyperpigmentation Disorder Treatment Market?
In July 2023, Reveal Lasers LLC, a US-based aesthetic laser and RF device manufacturer, merged with NEOconcepts LLC. Through this merger, Reveal Lasers has acquired the AgeJET Advanced Plasma Skin Therapy Device, enabling its expansion into a new treatment area and enhancing AgeJET's presence in the US region. NEOconcepts LLC is a US-based provider of aesthetic treatment products and devices.Regional Outlook
North America was the largest region in the hyperpigmentation disorders treatment market in 2025.Asia-Pacific is expected to be the fastest-growing region in the global hyperpigmentation disorder treatment market report during the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.What Defines the Hyperpigmentation Disorder Treatment Market?
The hyperpigmentation disorder treatment market consists of revenues earned by entities by providing hyperpigmentation disorder treatment services such as microdermabrasion and tropical treatment. The market value includes the value of related goods sold by the service provider or included within the service offering. The hyperpigmentation disorder treatment market also includes sales of serums, creams, gels or lotions formulated for the treatment of hyperpigmentation. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.How is Market Value Defined and Measured?
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.What Key Data and Analysis Are Included in the Hyperpigmentation Disorder Treatment Market Report 2026?
The hyperpigmentation disorder treatment market research report is one of a series of new reports from The Business Research Company that provides market statistics, including industry global market size, regional shares, competitors with the market share, detailed market segments, market trends and opportunities, and any further data you may need to thrive in the hyperpigmentation disorder treatment industry. The market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future state of the industry.Hyperpigmentation Disorder Treatment Market Report Forecast Analysis
| Report Attribute | Details |
|---|---|
| Market Size Value In 2026 | $6.65 billion |
| Revenue Forecast In 2035 | $9.36 billion |
| Growth Rate | CAGR of 8.5% from 2026 to 2035 |
| Base Year For Estimation | 2025 |
| Actual Estimates/Historical Data | 2020-2025 |
| Forecast Period | 2026 - 2030 - 2035 |
| Market Representation | Revenue in USD Billion and CAGR from 2026 to 2035 |
| Segments Covered | Treatment Type, Disease Indication, End-Users |
| Regional Scope | Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa |
| Country Scope | The countries covered in the report are Australia, Brazil, China, France, Germany, India, ... |
| Key Companies Profiled | Vivier Pharma, Obagi Cosmeceuticals LLC, EpiPharm AG, Laboratories Pierre Fabre, SkinCeuticals, Galderma S.A., Allergan PLC., Lumenis Be Ltd., Aerolase Corporation, Candela Corporation, Cynosure, PCA Skin, La Roche-Posay, L'Oréal S.A., Pierre Fabre Laboratories, Clinuvel Pharmaceuticals Ltd., Clarify Medical Inc., Dr. Reddy’s Laboratories Ltd., Glenmark Pharmaceuticals Ltd., SkinMedica Inc., Neutrogena Corporation, Paula's Choice Inc., ZO Skin Health Inc., Estée Lauder Companies Inc. |
| Customization Scope | Request for Customization |
| Pricing And Purchase Options | Explore Purchase Options |
